Panion & Bf Biotech Inc. (TPE:1760)

Market Cap	5.17B -12.4%
Revenue (ttm)	2.10B +4.4%
Net Income	213.71M +96.3%
EPS	2.48 +95.2%
Shares Out	85.74M
PE Ratio	24.33
Forward PE	n/a
Dividend	2.00 (3.32%)
Ex-Dividend Date	Jun 11, 2026

Volume	210,558
Open	59.90
Previous Close	59.70
Day's Range	59.90 - 61.00
52-Week Range	58.00 - 89.90
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Panion & Bf Biotech

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygien...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1976
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1760

Financial Performance

In 2025, Panion & Bf Biotech's revenue was 2.06 billion, an increase of 1.66% compared to the previous year's 2.03 billion. Earnings were 190.17 million, an increase of 52.72%.